CytRx Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (32)

Latest Posts

About This Stock More About This Stock
Top Performing Stocks In January And Seasonality
Article By: Cory Mitchell, CMT
Sunday, December 31, 2017 11:33 AM EST
January is not a good month for the stock market overall. The S&P 500 is usually flat to lower during the month. BUT, there are individual stocks that excel in January, rising at least 70% of the time and producing up to 17% gains during the month.
In this article: ALK, DIS, HRS, LEN, FAX, ALKS, CRUS, ERIC, XLNX, CYTR, EQC, OSK
Read
Incyte Rises After ASCO Abstracts, But Piper Urges Closer Look
Article By: The Fly
Wednesday, May 17, 2017 9:48 PM EST
The release of study abstracts for next month's ASCO conference drove significant moves tonight in drugmakers, but Piper Jaffray urged caution on the company's data, saying its "not sure what other investors are seeing that we aren't."
In this article: MRK, INCY, NLNK, AMGN, NKTR, CYTR, BLUE, LBIO, LPTX
Read
E Cytrx Shares Fall 66% After Phase 3 Sarcoma Trial Failure
Article By: Terry Chrisomalis
Tuesday, July 12, 2016 8:51 AM EST
The phase 3 trial recruited up to 433 patients to be treated for second-line soft tissue sarcoma. Shares of the company tumbled as data released showed that patients taking Aldoxorubicin failed to improve.
In this article: CYTR
Read
Tuesday Morning Pre-Market Insights: TSLA, SHAK, CYTR, EXAS
Article By: TipRanks
Tuesday, July 21, 2015 9:26 AM EST
Tesla Motors Inc. shares fell nearly -5% in pre-market trading after the company received a downgrade from Colin Langan at UBS. The analyst lowered his price target on the stock from $220 to $210.
In this article: CYTR, EXAS, GPRO, TSLA
Read
Cytrx Corporation Announces That FDA Has Removed Partial Clinical Hold For Cancer Drug
Article By: Terry Chrisomalis
Tuesday, January 20, 2015 11:55 AM EST
Trials currently in phase 2 testing Aldoxorubicin in cancer patients have a partial clinical hold lifted.
In this article: CYTR
Read

PARTNER HEADLINES

Latest Tweets for $CYTR

No tweets yet!